Delta-Fly Pharma

Basic Information

Stock Code
4598
Industry
Pharmaceuticals
Category Detail
Biotechnology & Pharmaceuticals
Prefecture
Tokushima Prefecture
Establishment Year
December 2010
Listing Year
October 2018
Official Website
https://www.delta-flypharma.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
GNI Group, Heartseed, Nexela Pharma, PeptiDream, SanBio, Helios, RenaScience, QualiPs, Takara Bio, Phoenix B, NCN, Flas, Japan Tissue Engineering

Overview

Delta-Fly Pharma is a biopharmaceutical venture established in 2010, specializing in the research and development of anti-cancer drugs using cutting-edge technologies.

Current Situation

Delta-Fly Pharma is an advanced pharmaceutical company specializing in anti-cancer drug discovery, focusing on R&D despite recording losses in the latest financial data. Since its establishment, it has promoted innovation in biopharmaceuticals with its base in Tokushima Prefecture and an office in Tokyo. Its core business is pharmaceutical development based on bio-drug discovery, advancing the creation of anti-cancer drug candidates utilizing gene-related technologies. It has secured investments from various venture capital firms and pharmaceutical companies, strengthening its capital base. Amid fierce competition with rivals, it emphasizes developing cutting-edge technologies and acquiring intellectual property. Moving forward, it aims to advance clinical trials for new drug candidates through proprietary technologies and achieve sustainable growth. Regarding sustainability, it is initiating efforts with interest in ethical drug discovery research and regional contributions. In the long term, it plans to expand its revenue base through domestic and international market development and strengthened partnerships.

Trivia

Interesting Facts

  • Gaining attention as a bio-drug discovery venture in Tokushima Prefecture
  • Achieved listing on Tokyo Stock Exchange Growth market within 10 years of establishment
  • One of the few Japanese companies specialized in gene editing technology
  • Major shareholder includes major pharmaceutical company Yakult
  • Success story as a regionally rooted venture in drug discovery
  • Deploys diverse research partnerships relative to company size
  • Compact organization with high expertise despite small staff
  • Attracts attention from Japan and abroad for cutting-edge technology research
  • Reported multiple times in Nikkei for stock acquisition rights issuances
  • Distributes much of R&D between Tokushima and Tokyo

Hidden Connections

  • Expected product sales cooperation through capital tie-up with Yakult headquarters
  • Strengthens academic collaboration through capital relations with Kyoto University venture
  • Receives financial support via Mitsubishi UFJ Capital
  • Shows market trends linked to prominent bio-related stocks
  • Has network with Mothers market listed companies
  • Leads formation of drug discovery cluster in Tokushima Prefecture
  • Gene-related technology culminates in unique technology differing from main competitors
  • Diverse R&D partners exist contrary to company size

Future Outlook

Growth Drivers

  • Market expansion due to increasing demand for anti-cancer drugs
  • Expanded utilization of advanced gene editing technology
  • Strengthened domestic and international partnerships
  • Increasing adoption of bio-drug discovery technology in pharmaceutical industry
  • Improvements in regulatory approval processes

Strategic Goals

  • Success in clinical trials and commercialization of new anti-cancer drugs
  • Growth into a drug discovery venture with annual sales of 10 billion yen
  • Global expansion of domestic and international partner collaborations
  • Ongoing promotion of sustainable pharmaceutical development
  • Completion of digitalization and automation of R&D facilities

Business Segments

Drug Discovery Support Services

Overview
Provides technology and reagent services across the entire drug discovery process to accelerate pharmaceutical development.
Competitiveness
High-precision drug discovery support platform using advanced gene technology
Customers
  • Bio ventures
  • Pharmaceutical companies' R&D departments
  • University research institutions
  • Public research institutes
  • Contract research organizations
  • Drug discovery seed holders
  • Medical ventures
  • Small and medium pharmaceutical companies
  • Pharmaceutical consultants
  • Clinical development companies
Products
  • Target identification technology
  • Novel compound screening
  • Biomarker research
  • Safety evaluation
  • Drug candidate evaluation support
  • Gene editing technology
  • Antibody development support
  • Cell-based assays
  • Data analysis services
  • Efficacy evaluation technology

Pharmaceutical Development Consulting

Overview
Offers consulting services for drug discovery and pharmaceutical development in general.
Competitiveness
High-quality proposals from a team of experts well-versed in drug discovery operations
Customers
  • Mid-sized pharmaceutical companies
  • Venture capital firms
  • Government agencies
  • Business partners
  • Overseas pharmaceutical companies
  • R&D firms
  • Medical institutions
  • Academia
  • Pharmaceutical application support departments
  • Pharmaceutical strategy teams
Products
  • Development strategy planning
  • Regulatory compliance support
  • Clinical development planning
  • Patent analysis
  • Fundraising support
  • Market research
  • Risk management
  • Quality assurance programs
  • Clinical trial design
  • Formulation design support

Biomarker Development

Overview
Supports biomarker research to enhance the efficacy and safety of drug discovery.
Competitiveness
Advanced analysis technology and diverse clinical collaboration networks
Customers
  • Pharmaceutical companies
  • Medical device developers
  • University hospitals
  • Research institutions
  • Clinical trial facilities
  • Health checkup centers
  • Diagnostic drug manufacturers
  • Pharmaceutical R&D departments
  • Bio-medical ventures
  • Clinical research organizations
Products
  • Biomarker discovery
  • Analysis services
  • Clinical data integration
  • Diagnostic method development
  • Contract research
  • Molecular target detection
  • Clinical trial support
  • Sample analysis
  • Gene expression analysis
  • Data integration platform

Pharmaceutical Manufacturing Contract

Overview
Provides contract manufacturing services for pharmaceuticals compliant with GMP standards.
Competitiveness
Strict quality control and capacity for small-batch, multi-product manufacturing
Customers
  • Small pharmaceutical companies
  • R&D companies
  • Generic manufacturers
  • Overseas bio companies
  • Contract manufacturers
  • New drug development ventures
  • Manufacturing technology support companies
  • University research institutions
  • Clinical trial manufacturing
  • Formulation development companies
Products
  • Pharmaceutical API manufacturing
  • Formulation manufacturing
  • Quality control
  • GMP-compliant manufacturing
  • Scale-up support
  • Process development
  • Component analysis
  • Packaging operations
  • Technology transfer support
  • Safety testing

Clinical Trial Support

Overview
Provides multifaceted support services to conduct clinical trials efficiently.
Competitiveness
Specialized support system in collaboration with drug discovery sites
Customers
  • Pharmaceutical companies
  • Medical institutions
  • Clinical trial sites
  • Contract research organizations
  • Pharmaceutical development consultants
  • Clinical research support companies
  • Pharmaceutical bio-ventures
  • Pharmaceutical management
  • Clinical trial monitoring organizations
  • Medical data analysis companies
Products
  • Clinical trial design
  • Monitoring
  • Data management
  • Regulatory compliance support
  • Trial site management
  • Subject recruitment
  • Quality assurance
  • Safety evaluation
  • Clinical data analysis
  • Report preparation

Intellectual Property Management

Overview
Provides comprehensive support for intellectual property related to drug discovery technologies.
Competitiveness
Handling by IP experts proficient in medical and bio knowledge
Customers
  • Pharmaceutical companies
  • Research institutions
  • Venture capital firms
  • Universities
  • Government agencies
  • IP consultants
  • Patent offices
  • Technology transfer organizations
  • New technology development companies
  • Licensing operators
Products
  • Patent application support
  • Technology evaluation
  • Rights management
  • Infringement investigation
  • License agreements
  • IP strategy planning
  • Technology transfer support
  • Legal consultation
  • IP training
  • Technical document preparation

Pharmaceutical Equipment Development Support

Overview
Develops and provides technical support services for pharmaceutical-related equipment.
Competitiveness
High-precision development based on needs from pharmaceutical research sites
Customers
  • Medical device manufacturers
  • Pharmaceutical companies
  • R&D departments
  • Prototype companies
  • Technology development ventures
  • University labs
  • Clinical development companies
  • Equipment distributors
  • Regulatory compliance departments
  • Manufacturing support companies
Products
  • Prototype model creation
  • Pharmaceutical equipment design
  • Performance evaluation
  • Regulatory compliance support
  • Manufacturing technology support
  • Safety testing
  • Material selection
  • Inspection equipment development
  • Quality control
  • Technical document preparation

Bio-Data Analysis Services

Overview
Provides advanced bio-data analysis for drug discovery and treatment exploration.
Competitiveness
Fusion of expert staff and the latest algorithms
Customers
  • Pharmaceutical companies
  • University researchers
  • Clinical data analysis companies
  • Medical institutions
  • Research institutes
  • Venture capital firms
  • Bioinformatics companies
  • Pharmaceutical R&D teams
  • Drug discovery support companies
  • Clinical research organizations
Products
  • Genomics analysis
  • Gene expression analysis
  • Biomarker analysis
  • Machine learning-based analysis
  • Data integration
  • Clinical data analysis
  • Molecular modeling support
  • Omics analysis
  • Data visualization
  • Report preparation

Joint Drug Discovery Research

Overview
Collaborative research ventures with external institutions and companies for new drug creation.
Competitiveness
Technology fusion and resource sharing through diverse partnerships
Customers
  • Universities
  • Pharmaceutical companies
  • Bio-ventures
  • Public research institutions
  • Medical institutions
  • Industry-academia collaboration organizations
  • Overseas research institutions
  • Pharmaceutical R&D
  • Clinical research organizations
  • Technology transfer organizations
Products
  • Joint drug discovery projects
  • Technology transfer
  • Research funding provision
  • IP sharing
  • Data exchange
  • New drug discovery technology development
  • Clinical collaboration
  • Joint clinical trials
  • Analysis tool sharing
  • Workshop hosting

Medical Education and Training Services

Overview
Provides specialized technical education and training programs related to drug discovery.
Competitiveness
Practical instruction by instructors with extensive on-site experience
Customers
  • Medical institutions
  • Pharmaceutical companies
  • Universities
  • Clinical research institutions
  • Medical ventures
  • Public institutions
  • Healthcare professionals
  • Research institutes
  • Healthcare companies
  • Academic societies
Products
  • Drug discovery technology training
  • Clinical research education
  • Pharmaceutical affairs courses
  • Webinar hosting
  • Technical guidance
  • Safety management training
  • IP education
  • Clinical trial monitor training
  • Data analysis education
  • Risk management guidance

Digital Health Collaboration

Overview
Pharmaceutical development and healthcare collaboration services utilizing digital technology.
Competitiveness
Advanced research system fusing bio and IT
Customers
  • Healthcare companies
  • Pharmaceutical companies
  • Medical device manufacturers
  • ICT companies
  • Bio-ventures
  • Clinical research organizations
  • Hospitals
  • Universities
  • Public institutions
  • IT solution companies
Products
  • Digital biomarker development
  • ICT-integrated drug discovery support
  • Remote monitoring technology
  • AI analysis tools
  • Patient data management
  • Clinical information integration
  • Clinical trial efficiency improvement
  • Digital therapeutics development
  • Health management support
  • Digital platforms

Competitive Advantage

Strengths

  • Possesses cutting-edge gene technology
  • Specialization focused on anti-cancer drug discovery
  • Solid funding from venture capital
  • Strengthened regional collaboration based in Tokushima Prefecture
  • Slim organization structure specialized in R&D
  • Good accessibility via Tokyo office
  • Promotes technology fusion through diverse joint research
  • Possesses innovative drug discovery platform
  • Strategic advancement of intellectual property rights
  • Differentiated technology based on deep science

Competitive Advantages

  • Surpasses competitors in drug discovery support using gene editing technology
  • Business focus narrowed to specialized anti-cancer drug development is a strength
  • Ensures stability through capital ties with numerous VCs and major pharmaceutical companies
  • Strengthens market access through partnerships with major unlisted bio companies
  • High uniqueness in target identification capabilities technologically
  • Agile research structure and quick decision-making despite small size
  • Strong information gathering leveraging ties with other companies' stocks
  • Establishes competitive superiority through specialized IP management
  • Sustainable management base benefiting from regional support
  • Improved recognition on Tokyo Stock Exchange Growth market and ease of fundraising

Threats

  • High costs and long-term risks in pharmaceutical development
  • Intensified market competition due to technological innovations by rival ventures
  • Delays from strengthened regulations and complex approval processes
  • Potential difficulties in research investment due to changes in fundraising environment
  • Risks of IP infringement lawsuits and patent expirations
  • Business downturn from clinical trial failures of main development products
  • Risk of stagnation in technology partnerships with major pharmaceutical companies
  • Uncertainty in market demand due to external environmental changes
  • Talent acquisition competition leading to outflow of excellent researchers
  • Delays in development plans due to impacts from novel infectious diseases, etc.

Innovations

2023: Announcement of New Anti-Cancer Drug Candidate Compound DTP-1

Overview
Published research results on anti-cancer drug candidate DTP-1 based on proprietary technology.
Impact
Establishes path to clinical trials

2022: Enhancement of Drug Discovery Support Platform

Overview
Introduced an integrated platform of gene editing technology and analysis tools.
Impact
Improves drug discovery speed by 30%

2021: Discovery of New Biomarkers through Joint Research

Overview
Identified biomarkers indicating anti-cancer drug efficacy in collaboration with a university.
Impact
Improves accuracy of treatment effect prediction

2020: Promotion of Digitalization of Research Facilities

Overview
Introduced AI-utilizing data management system to achieve efficiency.
Impact
Shortens research time by 15%

Sustainability

  • Promotion of ethical drug discovery research
  • Promotion of local employment
  • Eco-friendly research facility operations
  • Proper management of pharmaceutical waste
  • Funding for regional medical support